Autonomic Reactivity to Infant Crying in Maltreating Mothers.

We examined autonomic reactivity to infant crying in a sample of 42 maltreating and 38 non-maltreating mothers. Exploratively, we tested if differential reactivity was related to child neglect versus the combination of neglect and abuse, and we tested whether mothers' experiences with maltreatment in their own childhood moderated the association between their current maltreatment status and physiology. During a standardized cry paradigm, mothers listened to cry sounds of various pitches. Heart rate (HR), pre-ejection period (PEP), skin conductance levels (SCLs), and vagal tone (root mean square of successive differences [RMSSD]) were measured as indicators of underlying sympathetic and parasympathetic reactivity. The maltreating mothers showed lower SCL reactivity to the cry sounds than non-maltreating mothers. Furthermore, significant negative correlations between HR and PEP in the non-maltreating group differed from nonsignificant correlations in the maltreating group, which suggests a lack of sympathetic cardiac control in maltreating mothers. We found no differences between neglectful mothers and those who were additionally abusive. Together, our findings support the notion of sympathetic hypoarousal as a risk factor for child maltreatment, which may be indicative of disengagement in a caregiving context. Intervention programs might focus on improving maternal sensitivity to improve responsiveness to child signals.

Salivary levels of oxytocin remain elevated for more than two hours after intranasal oxytocin administration.

OBJECTIVE: This is the first study investigating whether levels of oxytocin in saliva remained elevated after intranasal oxytocin administration for the duration of an experiment (in which neurobehavioral effects of oxytocin were observed) taking more than two hours. METHODS: Oxytocin levels were measured in saliva samples collected from 57 female participants right before (T0), approximately 1» h (T1), and approximately 2» h (T2) after intranasal administration of 16 IU of oxytocin or a placebo, using a double-blind, within-subjects design. RESULTS: Average levels of oxytocin did not differ between conditions before use of the nasal spray, markedly increased only after oxytocin administration, and were still elevated after 2» h. CONCLUSION: Salivary levels of oxytocin remained persistently elevated over the course of our experiment, i.e. for more than two hours after intranasal oxytocin administration and over a time-period in which neurobehavioral effects of oxytocin are commonly observed. This suggests that salivary concentrations may be a valuable biomarker for oxytocin, and may help to explain its effects on brain activity, information processing, and behavior.